Home › Peptides A to Z › Methylene blue (non-peptide stack partner)What is Methylene blue (non-peptide stack partner)? Described as an electron cycler, not just a dye.
Methylene blue (non-peptide stack partner) in the library · · Human Trials · What are peptides?
135 registered trials · 458 indexed papers · 6425 human / 5458 animal studies
From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.
What it is Described as an electron cycler, not just a dye.
Registered human trials (135) Peer-reviewed studies (458) Paper Authors Journal Year Type The effect of photodynamic therapy on post-endodontic pain in treatments performed by undergraduate students Övsay E et al. BMC oral health 2026 Observational Study Antimicrobial photodynamic therapy improves wound quality and tissue repair in diabetic foot ulcers: A randomized double blind controlled clinical trial Chagas PF et al. Journal of photochemistry and photobiology. B, Biology 2026 Randomized Controlled Trial Comparison of compound methylene blue (methylene blue + ropivacaine) and bupivacaine liposome for pain control after mixed hemorrhoid surgery: A comprehensive analysis based on clinical studies Mai G et al. The Journal of international medical research 2026 Observational Study Efficacy of mechanical debridement with adjunct antimicrobial photodynamic therapy for the management of plaque-induced gingivitis in patients undergoing clear aligner therapy and fixed orthodontic therapy Al-Shammery D Photodiagnosis and photodynamic therapy 2026 Randomized Controlled Trial Prospective, randomized, controlled trial assessing the effects of methylene blue for the prevention of hypotension during renal replacement therapy: protocol paper and statistical analysis plan for the BLUE study Pontes CDN et al. Critical care science 2026 Clinical Study Clinical feasibility of chairside methylene blue-mediated photodynamic therapy for oral candidiasis Zhou P et al. BMC oral health 2026 Randomized Controlled Trial Comparison of antimicrobial photodynamic therapy protocols as adjunct treatment in the management of initial pericoronitis: a randomized, controlled, double-blind clinical trial Schalch TO et al. Clinical oral investigations 2026 Randomized Controlled Trial Comparison of methylene blue dye-based chromoendoscopy and Fujifilm virtual chromoendoscopy (blue light imaging and linked color imaging) for dysplasia detection in inflammatory bowel disease: a prospective single-center randomized study Alshatti Y et al. BMC gastroenterology 2026 Randomized Controlled Trial Methylene Blue Mouthwash for Oral Mucositis Pain in Cancer: An Open-Label, Non-Randomized Study Karow J et al. Journal of pain & palliative care pharmacotherapy 2026 Clinical Trial Clinical Efficacy of Adjunctive Photodynamic Therapy with Periodontal Regenerative Surgery in Severe Periodontitis: A Randomized Controlled Trial on Gingival Thickness Remodeling and Inflammatory Cytokine Modulation Huang D et al. Photobiomodulation, photomedicine, and laser surgery 2026 Randomized Controlled Trial An intraoperative methylene blue test can guide patient selection for totally tubeless PCNL Lee J et al. medRxiv : the preprint server for health sciences 2026 Preprint A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock Leung NY et al. Perfusion 2026 Observational Study Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass Teletnick A et al. Journal of cardiothoracic and vascular anesthesia 2026 Observational Study The effect of methylene blue infiltrating injection on anal pain after Milligan-Morgan surgery: A randomized controlled clinical study Zhu J et al. Medicine 2026 Randomized Controlled Trial Discovery of fluorescent properties in mitoxantrone hydrochloride injection for tracing: application for sentinel lymph node biopsy in breast cancer Li X et al. World journal of surgical oncology 2026 Randomized Controlled Trial Photodynamic Therapy Plus Topical Corticosteroid for Erosive Oral Lichen Planus: A Randomized Clinical Trial Wang Z et al. International dental journal 2026 Randomized Controlled Trial Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trial Luo JC et al. Scandinavian journal of trauma, resuscitation and emergency medicine 2026 Clinical Study Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease Wischik CM et al. The journal of prevention of Alzheimer's disease 2026 Randomized Controlled Trial Effect of photodynamic therapy on postoperative pain after pulpectomy in paediatric patients under general dental anaesthesia: A randomised controlled trial Zhang M et al. Photodiagnosis and photodynamic therapy 2026 Randomized Controlled Trial Intraoperative methylene blue infusion reduces postoperative delirium in patients undergoing pancreatic surgery: A randomized controlled clinical trial Deng Y et al. Journal of clinical anesthesia 2026 Randomized Controlled Trial Preoperative contrast-enhanced ultrasound combined with intra-lymph node methylene blue injection for sentinel lymph node identification: a minimally invasive sentinel lymph node biopsy tracing approach Liu Y et al. European radiology 2026 Randomized Controlled Trial Serratus Anterior Plane Block with Methylene Blue and Ropivacaine for Analgesia in Prosthetic Breast Augmentation: A Randomized Controlled Trial Zhang T et al. Plastic and reconstructive surgery 2026 Randomized Controlled Trial The Effect of Methylene Blue on Sublingual Microcirculation in Patients with Septic Shock: A Randomized Controlled Trial Dong C et al. Drug design, development and therapy 2025 Randomized Controlled Trial The clinical value of nanocarbon suspension and methylene blue in sentinel lymphatic tracing and pathologic fine sorting of penile cancer: a multicentre prospective study Liu C et al. Annals of medicine 2025 Randomized Controlled Trial Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial Alemany A et al. Frontiers in immunology 2025 Randomized Controlled Trial Development and evaluation of a novel prehospital antidote service providing methylthioninium chloride (methylene blue) for sodium nitrite poisoning Davies G et al. Emergency medicine journal : EMJ 2025 Observational Study Redefining scar quality: A synergistic approach with micro-needling and photodynamic therapy using methylene blue as a photosensitizer: a randomized clinical trial Sabetghadam M et al. Photodiagnosis and photodynamic therapy 2025 Randomized Controlled Trial Adjunctive methylene blue-based antimicrobial photodynamic therapy in the re-instrumentation of residual periodontal pockets in individuals with down syndrome: A randomized controlled clinical trial Petrilli PH et al. Journal of dentistry 2025 Randomized Controlled Trial IMPACT OF PHOTODYNAMIC THERAPY ON ORAL HEALTH IN PATIENTS UNDERGOING FIXED ORTHODONTIC TREATMENT: A RANDOMIZED CONTROLLED TRIAL Berisha N et al. Georgian medical news 2025 Randomized Controlled Trial Effect of intraoperative methylene blue on postoperative delirium in elderly patients undergoing joint replacement: a randomized controlled trial Zhang W et al. International journal of surgery (London, England) 2025 Randomized Controlled Trial
More cited research Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial (2020, human case report)Ultrasensitive Photoelectrochemical Biosensor Based on DNA Tetrahedron as Nanocarrier for Efficient Immobilization of CdTe QDs-Methylene Blue as Signal Probe wi (2018, human observational)Anti-Aging Potentials of Methylene Blue for Human Skin Longevity (2017, human observational)Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival (2017, human observational)Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's Disease (2024, animal)Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin (2021, animal)Methylene blue-loaded niosome: preparation, physicochemical characterization, and in vivo wound healing assessment (2020, animal)Removal of methylene blue dye using rice husk, cow dung and sludge biochar: Characterization, application, and kinetic studies (2020, animal)Conditions researched Fatigue & low energy (incl. midlife) Cognition, focus & brain performance Multiple sclerosis Migraine Dementia, Alzheimer's & cognitive decline Autism support Gum disease (periodontal) & oral health Pregnancy and breastfeeding: safety notes Anemia Diabetic retinopathy and glaucoma Acne Anti-aging & longevity Atherosclerosis, cardiovascular disease & high blood pressure Candida & persistent bacterial infections Celiac disease and gluten sensitivity Chronic and systemic inflammation EBV and reactivated viruses Fatty liver & elevated liver enzymes Fight-or-flight and nervous system overdrive Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers Hemorrhoids and fissures Herpes (HSV) and cold sores Hyperparathyroidism Immune system (general) Insulin resistance, prediabetes & type 2 diabetes Kidney protection (CKD, diabetic kidney, lupus kidney) Low blood pressure and orthostatic hypotension Lymphedema and swelling Osteoarthritis, cartilage loss & avoiding joint replacement Osteoporosis and bone density Post-surgical inflammation and surgery recovery Psoriasis and psoriatic arthritis Recurring UTIs Rheumatoid arthritis Skin, hair loss, wounds & mast-cell/histamine reactivity Tendon, ligament, muscle & joint injuries (incl. athletes) Thyroid problems Related compounds FAQ What is Methylene blue (non-peptide stack partner)? Described as an electron cycler, not just a dye.
How many registered human trials study Methylene blue (non-peptide stack partner)? The PeptideWhiz trial index lists 135 registered trials for Methylene blue (non-peptide stack partner), the most recent from 2027.
How much published research exists on Methylene blue (non-peptide stack partner)? The PeptideWhiz paper index links 458 PubMed papers to Methylene blue (non-peptide stack partner); by study type, 6425 human and 5458 animal studies.
Which conditions is Methylene blue (non-peptide stack partner) researched for? Fatigue & low energy (incl. midlife), Cognition, focus & brain performance, Multiple sclerosis, Migraine, Dementia, Alzheimer's & cognitive decline, Autism support, Gum disease (periodontal) & oral health, Pregnancy and breastfeeding: safety notes, Anemia, Diabetic retinopathy and glaucoma, Acne, Anti-aging & longevity, Atherosclerosis, cardiovascular disease & high blood pressure, Candida & persistent bacterial infections, Celiac disease and gluten sensitivity, Chronic and systemic inflammation, EBV and reactivated viruses, Fatty liver & elevated liver enzymes, Fight-or-flight and nervous system overdrive, Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers, Hemorrhoids and fissures, Herpes (HSV) and cold sores, Hyperparathyroidism, Immune system (general), Insulin resistance, prediabetes & type 2 diabetes, Kidney protection (CKD, diabetic kidney, lupus kidney), Low blood pressure and orthostatic hypotension, Lymphedema and swelling, Osteoarthritis, cartilage loss & avoiding joint replacement, Osteoporosis and bone density, Post-surgical inflammation and surgery recovery, Psoriasis and psoriatic arthritis, Recurring UTIs, Rheumatoid arthritis, Skin, hair loss, wounds & mast-cell/histamine reactivity, Tendon, ligament, muscle & joint injuries (incl. athletes), Thyroid problems.
Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).